Key facts
- This page summarizes Braden M. Leonard's Form 4 filing for Talis Biomedical Corp.
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Sep 2024, 16:24.
Braden M. Leonard - 05 Sep 2024 Form 4 Insider Report for Talis Biomedical Corp
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 05 Sep 2024
- Net transaction value
- +$44,240
- SEC form
- 4
- Accepted by SEC
- 09 Sep 2024, 16:24:12 UTC
- Prior SEC filing
- 05 Sep 2024
- Next SEC filing
- 16 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- Braden M Leonard
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Braden M. Leonard filed Form 4 for Talis Biomedical Corp on 09 Sep 2024.
Change
- Previous filing in this sequence was filed on 05 Sep 2024.
- Current net transaction value: +$44,240.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLIS
transaction
Common Stock
Purchase
- Transaction value
- $7,140
- Shares
- +5,100
- Change %
- +2.3%
- Price
- $1.40
- Shares after
- 223,702
- Date
- 05 Sep 2024
- Ownership
- Holding of BML Investment Partners, L.P.
- Footnotes
- F1
TLIS
transaction
Common Stock
Purchase
- Transaction value
- $37,100
- Shares
- +25,000
- Change %
- +11%
- Price
- $1.48
- Shares after
- 248,702
- Date
- 06 Sep 2024
- Ownership
- Holding of BML Investment Partners, L.P.
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.